| Primary |
| Drug Use For Unknown Indication |
27.4% |
| Product Used For Unknown Indication |
17.3% |
| Pain |
12.3% |
| Symphysiolysis |
7.1% |
| Alcohol Withdrawal Syndrome |
4.8% |
| Drug Exposure During Pregnancy |
4.5% |
| Back Pain |
4.2% |
| Cardiac Failure |
3.3% |
| Suicide Attempt |
2.7% |
| Cardiovascular Disorder |
2.5% |
| Migraine |
2.2% |
| Arthralgia |
1.6% |
| Constipation |
1.4% |
| Osteoarthritis |
1.4% |
| Pneumonia |
1.4% |
| Atrial Fibrillation |
1.2% |
| Depression |
1.2% |
| Ill-defined Disorder |
1.2% |
| Blood Cholesterol |
1.1% |
| Headache |
1.1% |
|
| Vomiting |
17.3% |
| Completed Suicide |
14.6% |
| Tinnitus |
9.2% |
| Overdose |
6.5% |
| Intentional Drug Misuse |
5.9% |
| Drug Abuse |
3.8% |
| Drug Toxicity |
3.8% |
| Intra-uterine Death |
3.8% |
| Drug Withdrawal Syndrome Neonatal |
3.2% |
| Intentional Overdose |
3.2% |
| Maternal Exposure During Pregnancy |
3.2% |
| Poisoning |
3.2% |
| Swelling Face |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| Cardio-respiratory Arrest |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Renal Failure |
2.7% |
| Somnolence |
2.7% |
| Swollen Tongue |
2.7% |
| Death |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
19.0% |
| Drug Use For Unknown Indication |
17.3% |
| Pain |
8.1% |
| Back Pain |
7.6% |
| Hypertension |
6.8% |
| Drug Exposure During Pregnancy |
6.0% |
| Overdose |
5.7% |
| Suicide Attempt |
3.7% |
| Symphysiolysis |
3.6% |
| Rheumatoid Arthritis |
3.0% |
| Arthralgia |
2.8% |
| Toothache |
2.7% |
| Atrial Fibrillation |
2.6% |
| Anaesthesia |
2.4% |
| Abdominal Pain Lower |
1.6% |
| Cardiac Failure |
1.6% |
| Alcohol Withdrawal Syndrome |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Intentional Self-injury |
1.3% |
| Muscle Relaxant Therapy |
1.3% |
|
| Completed Suicide |
20.8% |
| Drug Exposure During Pregnancy |
9.7% |
| Vomiting |
8.4% |
| Drug Toxicity |
6.5% |
| Renal Failure |
6.5% |
| Intra-uterine Death |
5.2% |
| Loss Of Consciousness |
3.9% |
| Overdose |
3.9% |
| Toxic Skin Eruption |
3.9% |
| Weight Increased |
3.9% |
| Cytolytic Hepatitis |
3.2% |
| Rhabdomyolysis |
3.2% |
| Death |
2.6% |
| Gastritis |
2.6% |
| Intentional Drug Misuse |
2.6% |
| Maternal Drugs Affecting Foetus |
2.6% |
| Multiple Drug Overdose Intentional |
2.6% |
| Neutropenia |
2.6% |
| Respiratory Arrest |
2.6% |
| Toxicity To Various Agents |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.3% |
| Drug Use For Unknown Indication |
14.7% |
| Rheumatoid Arthritis |
8.0% |
| Pain |
5.6% |
| Hypertension |
4.6% |
| Osteoarthritis |
2.8% |
| Depression |
2.1% |
| Prophylaxis |
1.9% |
| Back Pain |
1.8% |
| Nasopharyngitis |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Osteoporosis |
1.4% |
| Asthma |
1.3% |
| Diabetes Mellitus |
1.3% |
| Analgesic Therapy |
1.2% |
| Constipation |
1.2% |
| Atrial Fibrillation |
1.1% |
| Schizophrenia |
1.0% |
| Insomnia |
1.0% |
| Anxiety |
1.0% |
|
| Vomiting |
11.8% |
| Rhabdomyolysis |
7.2% |
| Fatigue |
6.6% |
| Drug Interaction |
5.4% |
| Myositis |
5.4% |
| Urinary Incontinence |
5.4% |
| Abdominal Pain |
4.9% |
| Cerebrovascular Accident |
4.6% |
| Interstitial Lung Disease |
4.6% |
| Renal Failure Acute |
4.6% |
| Anaphylactic Reaction |
4.3% |
| Psoriasis |
4.3% |
| Dyspnoea |
4.1% |
| Osteonecrosis |
4.1% |
| Hypotension |
3.8% |
| Malaise |
3.8% |
| Sepsis |
3.8% |
| Weight Decreased |
3.8% |
| Weight Increased |
3.8% |
| Death |
3.6% |
|
| Interacting |
| Pain |
68.2% |
| Contraception |
22.7% |
| Back Pain |
9.1% |
|
| Drug Interaction |
57.1% |
| Drug Ineffective |
14.3% |
| International Normalised Ratio Increased |
14.3% |
| Maternal Exposure During Pregnancy |
14.3% |
|
